Genprex inks sponsored research agreement with the University of Pittsburgh to study diabetes gene therapy in Type 1 and Type 2 diabetes

Join Pharma | Login

	Editorial


	THE FORCED SWIM TEST
	Tuesday, May 6, 2025
	The animal rights organization, People for the Ethical Treatment of Animals (PETA) has recently sent a letter to the Pharmacy Council of India (PCI) for discontinuing the Forced Swim Test (FST) in thousands of
	Past Editorial...

TODAY'S NEWS


10:00 [IST]	Genprex inks sponsored research agreement with the University of Pittsburgh to study diabetes gene therapy in Type 1 and Type 2 diabetes
09:15 [IST]	Medical devices industry welcomes UK-India FTA approval, raises certain concerns
09:00 [IST]	US FDA to expand use of unannounced inspections at foreign manufacturing facilities

more news >>

TOP NEWS


08:00 [IST]	Revised guidelines on biosimilars elaborates conditions for waiver of animal studies
08:00 [IST]	KRPA advocates for safe disposal practices of expired drugs
08:00 [IST]	Public health experts & patient groups ask govt to oppose TRIPS-plus provisions in FTAs
08:00 [IST]	Gujarat FDCA cracks down on antibiotic misuse to safeguard public health
08:00 [IST]	NPPA fixes retail prices of 84 new drugs
08:00 [IST]	DTAB ratifies extension of timeline for revised Schedule M implementation for MSMEs

more news >>

YESTERDAY'S NEWS


16:20 [IST]	Novopor acquires US-based Pressure Chemical Company to strengthen global specialty chemicals platform
16:10 [IST]	Poly Medicure net profit grows 34 per cent in Q4FY25
15:45 [IST]	Alembic Pharma reports 12% decline in net profit during Q4FY25
15:30 [IST]	Remidio’s Medios HI AI tools for glaucoma and AMD receives CDSCO approval
15:15 [IST]	ITC Dermafique launches the Dermafique Indian Skin Health Report; reveals Indian skin is unique and different from other ethnicities
14:50 [IST]	Granules India earns Gold Rating in EcoVadis Assessment ranks in the top 5% globally across all industries

more news >>

INTERVIEW


All DIs in TN are fully competent to inspect manufacturing units as per Revised Schedule M: MN Sridhar
MN Sridhar, director of the Tamil Nadu Drugs Control Department

Past Interviews...

	What's New?

Poly Medicure net profit grows 34 per cent in Q4FY25 Alembic Pharma reports 12% decline in net profit during Q4FY25 OneSource reports Rs. 426 crore revenues with 22% growth in Q4 & 30% rise at Rs. 1,444.9 crore in FY25 Syngene’s revenue from operations crossed Rs. 1,000 crore mark in Q4, PAT dips by 3%, full year earnings up 4% to Rs. 3,642 crore Methotrexate 2.5 Mg Tab/cap

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers